Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton
The phosphoinositide 3-kinase (PI3K) pathway regulates multiple steps in glucose metabolism and also cytoskeletal functions, such as cell movement and attachment. Here, we show that PI3K directly coordinates glycolysis with cytoskeletal dynamics in an AKT-independent manner. Growth factors or insulin stimulate the PI3K-dependent activation of Rac, leading to disruption of the actin cytoskeleton, release of filamentous actin-bound aldolase A, and an increase in aldolase activity. Consistently, PI3K inhibitors, but not AKT, SGK, or mTOR inhibitors, cause a significant decrease in glycolysis at the step catalyzed by aldolase, while activating PIK3CA mutations have the opposite effect. These results point toward a master regulatory function of PI3K that integrates an epithelial cell's metabolism and its form, shape, and function, coordinating glycolysis with the energy-intensive dynamics of actin remodeling..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:164 |
|---|---|
| Enthalten in: |
Cell - 164(2016), 3, Seite 433-446 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Albeck, John G [VerfasserIn] |
|---|
| Links: |
|---|
| RVK: |
|---|
| doi: |
10.1016/j.cell.2015.12.042 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1970575425 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1970575425 | ||
| 003 | DE-627 | ||
| 005 | 20230518190651.0 | ||
| 007 | tu | ||
| 008 | 160212s2016 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cell.2015.12.042 |2 doi | |
| 028 | 5 | 2 | |a PQ20160212 |
| 035 | |a (DE-627)OLC1970575425 | ||
| 035 | |a (DE-599)GBVOLC1970575425 | ||
| 035 | |a (PRQ)c666-28e0debfc0b245810615baec06136bcf5f54d09a087e15e826007d53df4a6a160 | ||
| 035 | |a (KEY)0030308920160000164000300433phosphoinositide3kinaseregulatesglycolysisthroughm | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |a 610 |q DNB |
| 084 | |a XA 36269 |q AVZ |2 rvk | ||
| 100 | 1 | |a Albeck, John G |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a The phosphoinositide 3-kinase (PI3K) pathway regulates multiple steps in glucose metabolism and also cytoskeletal functions, such as cell movement and attachment. Here, we show that PI3K directly coordinates glycolysis with cytoskeletal dynamics in an AKT-independent manner. Growth factors or insulin stimulate the PI3K-dependent activation of Rac, leading to disruption of the actin cytoskeleton, release of filamentous actin-bound aldolase A, and an increase in aldolase activity. Consistently, PI3K inhibitors, but not AKT, SGK, or mTOR inhibitors, cause a significant decrease in glycolysis at the step catalyzed by aldolase, while activating PIK3CA mutations have the opposite effect. These results point toward a master regulatory function of PI3K that integrates an epithelial cell's metabolism and its form, shape, and function, coordinating glycolysis with the energy-intensive dynamics of actin remodeling. | ||
| 540 | |a Nutzungsrecht: Copyright © 2016 Elsevier Inc. All rights reserved. | ||
| 700 | 1 | |a Seth, Pankaj |4 oth | |
| 700 | 1 | |a Grant, Aaron K |4 oth | |
| 700 | 1 | |a Wulf, Gerburg M |4 oth | |
| 700 | 1 | |a Lyssiotis, Costas A |4 oth | |
| 700 | 1 | |a Cantley, Lewis C |4 oth | |
| 700 | 1 | |a Lauring, Josh |4 oth | |
| 700 | 1 | |a Varma, Gopal |4 oth | |
| 700 | 1 | |a Hung, Yin Pun |4 oth | |
| 700 | 1 | |a Juvekar, Ashish |4 oth | |
| 700 | 1 | |a Oh, Doogie |4 oth | |
| 700 | 1 | |a Tolan, Dean R |4 oth | |
| 700 | 1 | |a Hu, Hai |4 oth | |
| 700 | 1 | |a Needleman, Daniel J |4 oth | |
| 700 | 1 | |a Asara, John M |4 oth | |
| 700 | 1 | |a Lundquist, Mark R |4 oth | |
| 700 | 1 | |a Lien, Evan C |4 oth | |
| 700 | 1 | |a Ullas, Soumya |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Cell |d Cambridge, Mass. : Cell Press, 1974 |g 164(2016), 3, Seite 433-446 |w (DE-627)129403725 |w (DE-600)187009-9 |w (DE-576)014785382 |x 0092-8674 |7 nnns |
| 773 | 1 | 8 | |g volume:164 |g year:2016 |g number:3 |g pages:433-446 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.cell.2015.12.042 |3 Volltext |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26824656 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-CHE | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_2004 | ||
| 912 | |a GBV_ILN_2219 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | r | v | |a XA 36269 |
| 951 | |a AR | ||
| 952 | |d 164 |j 2016 |e 3 |h 433-446 | ||